It requires understanding what separates genuine research-grade retatrutide from the questionable material flooding the market
In early 2026, Hims & Hers announced its intention to market a compounded version of Novo Nordisks oral semaglutide product
The most common include nausea, constipation, and injection site reactions during early dose titration
Below are answers to common questions about obesity treatment, GLP-1 medications, bariatric surgery, telehealth visits, insurance coverage, and self-pay weight loss programs for patients in Aventura and South Florida
some patients and clinicians report better sleep during treatment, though controlled trial data in women specifically is limited Associated with improved body composition, including reduced abdominal fat and preservation of lean muscle
adults take a GLP-1